|COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring.|
Engineering and medicine: Opportunities in type 1 diabetes
If you have a question about this talk, please contact Dr Jason Z JIANG.
The development of the artificial pancreas is underway with considerable stakeholders input and industry interest. Aimed to treat type 1 diabetes of all ages from early childhood to maturity, the artificial pancreas consists of a continuous glucose meter, control algorithm and an insulin pump. Significant life sciences opportunities exist to complement the clinical work and accelerate research progress and commercialisation of the artificial pancreas.
This talk is part of the CUED Control Group Seminars series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
Other listsMicrosoft Research Machine Learning and Perception Seminars Cambridge Neuroscience Seminars IoA Stellar Pops
Other talksExoplanets from WASP to PLATO Dark Matter TReND: Teaching and Research in Neuroscience for Development in Africa Machines and Markets: The Island Matching Engine and the Inversion of Finance I spy with my MRI.... Familial thrombocytopenias with predisposition to leukemia: RUNX1 targets